JP2010509241A5 - - Google Patents

Download PDF

Info

Publication number
JP2010509241A5
JP2010509241A5 JP2009535502A JP2009535502A JP2010509241A5 JP 2010509241 A5 JP2010509241 A5 JP 2010509241A5 JP 2009535502 A JP2009535502 A JP 2009535502A JP 2009535502 A JP2009535502 A JP 2009535502A JP 2010509241 A5 JP2010509241 A5 JP 2010509241A5
Authority
JP
Japan
Prior art keywords
inhibition
peptide
nanoparticles
combinations
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2009535502A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010509241A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/083772 external-priority patent/WO2008058125A2/en
Publication of JP2010509241A publication Critical patent/JP2010509241A/ja
Publication of JP2010509241A5 publication Critical patent/JP2010509241A5/ja
Withdrawn legal-status Critical Current

Links

JP2009535502A 2006-11-07 2007-11-06 膜貫通ペプチドからなる自己凝集性ナノ粒子および抗癌剤の特異的腫瘍内送達のためのその利用 Withdrawn JP2010509241A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86466506P 2006-11-07 2006-11-07
PCT/US2007/083772 WO2008058125A2 (en) 2006-11-07 2007-11-06 Self-assembling nanoparticles composed of transmembrane peptides and their application for specific intra-tumor delivery of anti-cancer drugs

Publications (2)

Publication Number Publication Date
JP2010509241A JP2010509241A (ja) 2010-03-25
JP2010509241A5 true JP2010509241A5 (cg-RX-API-DMAC7.html) 2010-12-09

Family

ID=39365311

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009535502A Withdrawn JP2010509241A (ja) 2006-11-07 2007-11-06 膜貫通ペプチドからなる自己凝集性ナノ粒子および抗癌剤の特異的腫瘍内送達のためのその利用

Country Status (9)

Country Link
US (1) US9326950B2 (cg-RX-API-DMAC7.html)
EP (1) EP2086521A2 (cg-RX-API-DMAC7.html)
JP (1) JP2010509241A (cg-RX-API-DMAC7.html)
CN (1) CN101610759A (cg-RX-API-DMAC7.html)
AU (1) AU2007316416A1 (cg-RX-API-DMAC7.html)
CA (1) CA2668638A1 (cg-RX-API-DMAC7.html)
NZ (1) NZ576769A (cg-RX-API-DMAC7.html)
WO (1) WO2008058125A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA200903125B (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101610759A (zh) * 2006-11-07 2009-12-23 美国政府卫生与公共服务部 由跨膜肽组成的自组装纳米颗粒及其用于特异性肿瘤内递送抗癌药物的应用
WO2012162628A2 (en) 2011-05-25 2012-11-29 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Lipopeptide inhibitors of ras oncoproteins
US9180203B2 (en) 2012-10-23 2015-11-10 The Johns Hopkins University Self-assembling drug amphiphiles and methods for synthesis and use
ES2625024B1 (es) * 2015-12-18 2018-05-10 Consejo Superior De Investigaciones Cientificas Material que comprende tectómeros de oligoglicina y nanohilos
US11246924B2 (en) 2016-04-01 2022-02-15 Duke University Alpha-helical peptide nanofibers as a self-adjuvanting vaccine platform
WO2019018572A1 (en) * 2017-07-18 2019-01-24 Duke University COMPOSITIONS AND METHODS COMPRISING SELF-ASSEMBLY PEPTIDE-POLYMER NANOFIBERS FOR SUBLINGUAL IMMUNIZATION

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6187775B1 (en) 1996-04-12 2001-02-13 The United States Of America As Represented By The Department Of Health And Human Services Acridone-derived compounds useful as antineoplastic and antiretroviral agents
US7105488B1 (en) 1998-02-27 2006-09-12 The United States Of America As Represented By The Department Of Health And Human Services G protein-coupled receptor antagonists
WO1999043711A1 (en) 1998-02-27 1999-09-02 The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services G protein-coupled receptor antagonists
US7517849B1 (en) * 1999-11-18 2009-04-14 The United States Of America As Represented By The Secretary Of Health And Human Services Inhibition of ABC transporters by transmembrane domain analogs
ATE250603T1 (de) 2000-03-07 2003-10-15 Us Gov Health & Human Serv 1,8-naphthalimid imidazo(4,5,1-de)acridone mit antitumorwirkung
AU2001275423B2 (en) * 2000-06-09 2007-01-11 Regulon, Inc. Encapsulation of polynucleotides and drugs into targeted liposomes
AU2002240201A1 (en) * 2001-02-02 2002-08-19 Yale University Peptides for facilitating composite receptor expression and translocation of macromolecules
WO2006010083A2 (en) * 2004-07-08 2006-01-26 Molecular Therapeutics, Inc. Biodegradable nanoparticles
CN101610759A (zh) * 2006-11-07 2009-12-23 美国政府卫生与公共服务部 由跨膜肽组成的自组装纳米颗粒及其用于特异性肿瘤内递送抗癌药物的应用

Similar Documents

Publication Publication Date Title
Sedighi et al. Multifunctional self-assembled peptide hydrogels for biomedical applications
Wang et al. Recent advances in the fabrication, functionalization, and bioapplications of peptide hydrogels
AU2024202093A1 (en) Peptides and nanoparticles for intracellular delivery of mrna
Ge et al. Biological applications of water-soluble polypeptides with ordered secondary structures
JP6881813B2 (ja) 核酸ワクチン
KR102714709B1 (ko) 조건부 활성 폴리펩티드
Tikhomirov et al. Exosomes: from potential culprits to new therapeutic promise in the setting of cardiac fibrosis
CN111132999A (zh) 支架蛋白
KR20140103914A (ko) 운반물 경피 전달을 포함하는 타켓 전달용 다공성 나노입자-지지 지질 이중층(프로토셀) 및 그 방법
JP2010509241A5 (cg-RX-API-DMAC7.html)
JP2014500867A (ja) 皮膚浸透性および細胞侵入性(space)ペプチドとその使用法
JP6175055B2 (ja) ウイルス感染増強特性を有するペプチドおよびその使用
AU2024203377A1 (en) Altering inflammatory states of immune cells in vivo by modulating cellular activation states
CN111787912A (zh) 用于核酸分子递送的纳米颗粒-水凝胶复合物
JP5721729B2 (ja) 活性産生送達分子
Scognamiglio et al. Dancing with Nucleobases: Unveiling the Self-Assembly Properties of DNA and RNA Base-Containing Molecules for Gel Formation
KR101336552B1 (ko) 전립선암 특이적 siRNA 전달체
CN118201625A9 (zh) 微藻胞外囊泡、其制备和用途
CN120037351A (zh) 一种新降解途径的蛋白质降解治疗疾病的组合物
CN102703584A (zh) 自组装聚合分支dna探针的制备方法
Gándara et al. Delivery of Therapeutic Biopolymers Employing Silica-Based Nanosystems
Hamsici et al. Drug Delivery Applications of Peptide Materials
WO2015199309A1 (ko) 양이온성 분자 수송체 및 음이온성 생리활성 물질을 포함하는 피부 투과용 조성물
JP2016535600A5 (cg-RX-API-DMAC7.html)
CN117069799B (zh) 细胞穿膜肽及其应用